Business opportunity
Domain Therapeutics is willing to enter into collaboration with Pharma and Biotech companies to discover innovative drug candidates in the GPCR fields.
Partner can enter the collaboration at different levels:
- At the gene level for an assay development and next steps until optimized lead
- At the assay level, taking advantage of one of the assays already developed
- At the hit stage for GLP-1R program
Several deal structures from fee for service to strategic alliances can be envisaged for those interested in working with Domain Therapeutics. |
